| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/28/2011 | WO2011090266A2 Novel tumor antigen protein agr2 and tumor antigenic peptide thereof |
| 07/28/2011 | WO2011089921A1 Modified melk peptides and vaccines containing the same |
| 07/28/2011 | WO2011089288A1 Composition comprising gdnf and tgf-β1 and use thereof for the treatment of a neurological disease |
| 07/28/2011 | WO2011089225A1 Use of aprotinin for treating parasitic infections and prognosing bovine trypanotolerance |
| 07/28/2011 | WO2011089203A1 Pharmaceutical composition for treating a metabolic syndrome |
| 07/28/2011 | WO2011089170A2 Process for preparing fgf-21 with low degree of o-glycosylation |
| 07/28/2011 | WO2011089167A1 Kombination of proteasome inhibitors and anti -hepatitis medication for treating retroviral diseases |
| 07/28/2011 | WO2011089166A1 Semicarbazone proteasome inhibitors for treating hiv and hepatitis infection |
| 07/28/2011 | WO2011089152A1 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
| 07/28/2011 | WO2011088837A1 Treatment of cardiac conditions |
| 07/28/2011 | WO2011088751A1 A human factor ix slow release dosage form |
| 07/28/2011 | WO2011088605A1 Use of leptin in enhancing therapeutic efficacy of medroxyprogesterone acetate on liver cancer |
| 07/28/2011 | WO2011069164A3 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
| 07/28/2011 | WO2011060371A3 Factor viii t cell epitope variants having reduced immunogenicity |
| 07/28/2011 | WO2011050342A3 Rational design of a biocompatible synthetic laminin-111 polymer and uses thereof |
| 07/28/2011 | WO2011047091A9 Methods for treating traumatic brain injury |
| 07/28/2011 | WO2011038061A3 Novel npr-b agonists |
| 07/28/2011 | WO2010101301A9 Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein |
| 07/28/2011 | WO2010083034A9 Methods for increasing adiponectin |
| 07/28/2011 | WO2009071283A3 Therapeutic use of desacyl ghrelin |
| 07/28/2011 | WO2008089243A3 The redox/fyn/c-cbl pathway |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184379 Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools |
| 07/28/2011 | US20110184220 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110183925 Anti-inflammatory peptide |
| 07/28/2011 | US20110183924 Methods and systems for annotating biomolecular sequences |
| 07/28/2011 | US20110183923 Peptide antagonists of zonulin and methods for use of the same |
| 07/28/2011 | US20110183922 Peptides that enhance acetylcholinesterase expression |
| 07/28/2011 | US20110183921 Peptides capable of modulating the function of tirc7 |
| 07/28/2011 | US20110183920 Modified il-4 mutein receptor antagonists |
| 07/28/2011 | US20110183919 Novel dipeptidyl peptidase iv (dp-iv) compounds |
| 07/28/2011 | US20110183918 Method of Treating Leukemia Using Rcie Prolamin |
| 07/28/2011 | US20110183917 P53 Activator Peptides |
| 07/28/2011 | US20110183916 Apo-2 Ligand |
| 07/28/2011 | US20110183915 Small Molecule Cancer Treatments that cause Necrosis in Cancer Cells but do not Affect Normal Cells |
| 07/28/2011 | US20110183912 Agent for promoting neuronal differentiation and method therefor |
| 07/28/2011 | US20110183911 Method for improving neurotransmission failure using a novel agent |
| 07/28/2011 | US20110183910 Biglycan and related therapeutics and methods of use |
| 07/28/2011 | US20110183909 Treatment of Mood and Anxiety Disorders |
| 07/28/2011 | US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183906 Factor ix conjugates with extended half-lives |
| 07/28/2011 | US20110183905 Pharmaceutical compositions |
| 07/28/2011 | US20110183904 Methods and compositions for altering behavior associated with autism spectrum disorder |
| 07/28/2011 | US20110183903 USE OF PEGylated IGF-I VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS |
| 07/28/2011 | US20110183902 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition |
| 07/28/2011 | US20110183901 Superior Control of Blood Glucose in Diabetes Treatment |
| 07/28/2011 | US20110183900 High Caloric Enteral Formulations |
| 07/28/2011 | US20110183899 Methods and compositions for the treatment of obesity |
| 07/28/2011 | US20110183898 Compositions for delivering peptide yy and pyy ag0nists |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |
| 07/28/2011 | US20110183895 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 07/28/2011 | US20110183894 Antiviral activity of the protein scytovirin and methods of use |
| 07/28/2011 | US20110183893 Non-natural mic proteins |
| 07/28/2011 | US20110183892 Methods for the treatment of viral conditions |
| 07/28/2011 | US20110183891 Methods and Compositions for Inhibiting Fungal Infection and Disease |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110183889 Salicylanilide modified peptides for use as oral therapeutics |
| 07/28/2011 | US20110183888 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| 07/28/2011 | US20110183887 Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| 07/28/2011 | US20110183886 Melanocortin receptor ligands |
| 07/28/2011 | US20110183885 Neo-tryptophan |
| 07/28/2011 | US20110183884 Pan-antiviral peptides for protein kinase inhibition |
| 07/28/2011 | US20110183416 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 07/28/2011 | US20110183375 Metal binding compounds and their use in cell culture medium compositions |
| 07/28/2011 | US20110183008 Lactoferrin |
| 07/28/2011 | US20110182998 Microspheres useful for therapeutic vascular embolization |
| 07/28/2011 | US20110182995 Medical and dental biomaterial and method of use for the same |
| 07/28/2011 | US20110182992 Peptides and peptide mimetics to treat pathologies associated with eye disease |
| 07/28/2011 | US20110182991 Method for improved fibrin sealing |
| 07/28/2011 | US20110182989 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |
| 07/28/2011 | US20110182986 Controlled release composition |
| 07/28/2011 | US20110182982 Liposome treatment of viral infections |
| 07/28/2011 | US20110182979 In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation |
| 07/28/2011 | US20110182978 Activated nitric oxide donors and methods of making and using thereof |
| 07/28/2011 | US20110182969 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/28/2011 | US20110182968 Interpenetrating polymer network hydrogel corneal prosthesis |
| 07/28/2011 | US20110182965 Highly compression resistant matrix with porous skeleton |
| 07/28/2011 | US20110182963 Osteoimplant and methods for making |
| 07/28/2011 | US20110182962 resorbable matrix having elongated particles |
| 07/28/2011 | US20110182948 Method for treating disease characterized by plaque |
| 07/28/2011 | US20110182928 Vaccine against amyloid folding intermediate |
| 07/28/2011 | US20110182927 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 07/28/2011 | US20110182922 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 07/28/2011 | US20110182921 Regulatory t cell epitopes, compositions and uses thereof |
| 07/28/2011 | US20110182920 Identification of a novel cysteine-rich cell penetrating peptide |
| 07/28/2011 | US20110182916 Use of Agonists of Integrin Alpha 5 for Inducing the Osteogenic Differentiation of Mesenchymal Stem Cells |
| 07/28/2011 | US20110182914 Methods and compositions |
| 07/28/2011 | US20110182912 Agents and methods for denervation |
| 07/28/2011 | US20110182911 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 07/28/2011 | US20110182910 Method of treating t cell mediated disorders |
| 07/28/2011 | US20110182908 Diagnostics and Therapeutics for Macular Degeneration-Related Disorders |
| 07/28/2011 | US20110182903 Novel soluble cd83 polypeptides, formulations and methods of use |
| 07/28/2011 | US20110182897 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182891 Pharmaceutical dosage form comprising polymeric carrier composition |
| 07/28/2011 | US20110182890 Anti-pleiotrophin antibodies and methods of use thereof |
| 07/28/2011 | US20110182886 Compositions and methods for inhibiting tumor progression |